If you are reading this in your 40s, you are at the most useful inflection point of your adult life. Most men feel fine. That is the problem.

Atherosclerosis — the slow buildup of plaque inside arteries — does not begin in your 60s. It begins in your 20s and 30s, and by your 40s it is already silently advanced in a meaningful minority of healthy-feeling men. The 2019 European Society of Cardiology dyslipidaemia guidelines (Mach et al., European Heart Journal) are clear that the goal is to reduce lifetime exposure to atherogenic particles, not to wait for symptoms.

The driving particle is apolipoprotein B (ApoB) — a single number that counts every atherogenic lipoprotein, including LDL, VLDL, IDL, and lipoprotein(a). Standard total cholesterol and LDL-C miss particle count in roughly a quarter of men, especially those with metabolic syndrome or insulin resistance. Asking your physician for an ApoB measurement once in your 40s is one of the highest-value blood draws of your life.

Separately, lipoprotein(a) — Lp(a) — is a genetically determined risk factor independent of LDL that statins barely touch. The 2022 European Atherosclerosis Society consensus (Kronenberg et al., European Heart Journal) recommends measuring Lp(a) at least once in adulthood for every adult. Elevated Lp(a) is a rule-in cardiovascular risk-enhancer above roughly 50 mg/dL (≈125 nmol/L); levels around 100 mg/dL roughly double atherosclerotic cardiovascular risk (Kronenberg et al., 2022) and should change how aggressively you and your physician manage everything else.

In your 40s you are not treating disease, you are buying decades. The cheapest decade to buy is the one that has not started yet.

Testosterone is the topic most distorted by aggressive marketing. A real medical condition (hypogonadism) sits next to a real lifestyle effect (modest age-related decline), and they require very different responses.

The age effect. Total testosterone declines roughly 1–2% per year on average after age 40, but the spread between men is huge. The European Male Aging Study (Wu et al., NEJM 2010) showed that genuine late-onset hypogonadism — low testosterone plus symptoms — affects only about 2% of men aged 40–79. Other men with somewhat lower readings usually sit inside the wide normal range or have values driven by obesity, untreated sleep apnea, alcohol, or chronic stress, all reversible.

The medical indication. The Endocrine Society's 2018 clinical practice guideline (Bhasin et al.) recommends testosterone replacement therapy only for men with consistently low morning total testosterone on two separate measurements plus symptoms of androgen deficiency. European urological guidance agrees. A single borderline-low result while you are stressed or sleep-deprived is not a diagnosis.

The cardiovascular safety question. The TRAVERSE trial (Lincoff et al., NEJM 2023) — the largest randomized cardiovascular safety trial of testosterone in middle-aged and older men with hypogonadism and cardiovascular risk — found testosterone replacement non-inferior to placebo for major adverse cardiovascular events over a mean 33 months. Reassuring for the indicated population — not an endorsement of testosterone as an anti-aging supplement for men with normal levels.

About lifestyle. Sleep, body composition, training, alcohol use, and metabolic health all affect endogenous testosterone, but the effect sizes are modest. There is no validated 'natural T-booster' supplement.

Low-T clinics. Some clinics aggressively market testosterone for men whose levels are not clinically low. Insist on two morning measurements, a real symptom assessment, evaluation of obesity and sleep apnea first — and a physician, not a salesperson.

Lean muscle mass and grip strength predict all-cause mortality across many studies. Muscle is also where most of your insulin sensitivity lives. The decade where you can most cheaply protect it is this one.

The framework. The revised European Working Group on Sarcopenia in Older People consensus (EWGSOP2; Cruz-Jentoft et al., Age and Ageing 2019) defines sarcopenia primarily by low muscle strength, confirmed by muscle quantity and quality. Practical screening is straightforward: how heavy you can lift, how fast you stand from a chair, how strong your grip is. If you lose strength faster than average across your 40s and 50s, sarcopenia in your 70s is far more likely.

Resistance training. There is no substitute. Two to four sessions per week — covering squat, hinge, push, pull, and carry — is the most evidence-supported physical activity for healthspan in midlife. Progressive overload matters more than the split. Pair with regular zone 2 cardio and occasional higher-intensity work; large prospective analyses consistently show that meeting and exceeding physical-activity guidelines is associated with substantially lower all-cause mortality, in both healthy adults and patients with cardiovascular disease.

Protein. Needs rise with age. Expert consensus for older adults recommends roughly 1.0–1.2 g protein per kg body weight per day, with higher intakes (up to ~1.5 g/kg/day) for active or recovering men. The practical lesson: hit a real protein target at most meals — especially breakfast, where many men under-eat protein and over-eat refined carbohydrate.

Don't fear muscle. Compound lifts at moderate-to-high effort, with reasonable form and adequate recovery, are not dangerous for healthy adults — they are protective. If you have never trained, hire a coach for six to twelve weeks.

Cardiovascular disease remains the leading cause of death for men in the US and DACH. The 40s and 50s are the window where most modifiable damage is done — and most prevention works.

Numbers worth knowing. Beyond total cholesterol and LDL-C, ask once for ApoB, Lp(a), HbA1c, fasting insulin (or HOMA-IR), high-sensitivity CRP (hsCRP), and a basic liver panel. The 2019 ESC/EAS dyslipidaemia guideline (Mach et al.) emphasizes risk-based LDL/ApoB targets — your 'normal' lab range is not the same as your individual target if you carry elevated Lp(a), strong family history, or metabolic syndrome.

Blood pressure. Get accurate readings at home, not just at the doctor's office. White-coat effects routinely add 5–15 mmHg. A cheap upper-arm cuff (not wrist) used correctly is one of the best longevity investments under 50 euros.

Visceral fat. Waist circumference is crude but useful. A waist above ~94 cm (37 in) increases metabolic risk; above ~102 cm (40 in) substantially so. The mechanism connecting abdominal fat, insulin resistance, fatty liver, and cardiovascular disease is the same — fixing one usually helps the others.

Alcohol — the honest reckoning. The largest individual-participant meta-analysis of nearly 600,000 drinkers (Wood et al., Lancet 2018) found that all-cause mortality risk increased above roughly 100 g of pure alcohol per week — roughly 7 US standard drinks, ~12 UK units, or ~8–10 German Standardgetränke. There is no clean 'protective dose'. For men whose social life centers on Wiesn, Stammtisch, après-ski, or the office Friday round, the goal is honest awareness, not moralism. Replacing one or two heavy weeks per month with light or alcohol-free ones is realistic and meaningful. Alkoholfreies Bier exists and is, by mortality data, a better friend than its alcoholic cousin.

Smoking. If you still smoke, this is the highest-leverage thing you can change. Vaping is not a long-term solution but, as a bridge, is better than continuing to smoke.

Sleep duration. Adult sleep consensus broadly recommends 7–9 hours per night. Habitual short sleep is associated with cardiovascular disease, metabolic disease, dementia risk, and lower testosterone. If you've been telling yourself for years that you do fine on six, you almost certainly do not.

Sleep apnea. Obstructive sleep apnea (OSA) is dramatically underdiagnosed in men 40+, especially those who snore, are overweight, or have a thick neck. It silently drives hypertension, fatigue, atrial fibrillation, and low testosterone. If your partner reports snoring or witnessed pauses in breathing, or you wake unrefreshed, ask your Hausarzt about a screening sleep study. Many cases improve with weight loss, positional therapy, or CPAP.

Mental health in midlife. Depression in midlife men often presents as irritability, withdrawal, loss of interest, increased drinking, and a feeling of being 'flat' rather than classic sadness. Many men spend years attributing this to work or low testosterone when the underlying issue is depression. Suicide rates in middle-aged men in DACH and the US are persistently high. If something feels wrong for more than a couple of weeks, talk to your physician — or, in Germany, call the Telefonseelsorge 0800 111 0111 (free, 24/7) or Männerhilfetelefon 0800 123 99 00 (Mon–Thu 08–20, Fri 08–15; originally for men experiencing violence, but staffed to triage broader distress). In Austria, Telefonseelsorge 142. In Switzerland, Die Dargebotene Hand 143. In the US, the 988 Suicide & Crisis Lifeline. Asking for help is not a hormone problem.

Prostate screening — the nuanced version. Prostate cancer screening is one of the most contested topics in men's health. The European ERSPC trial (Hugosson et al., European Urology 2019) showed that PSA screening reduces prostate-cancer-specific mortality by approximately 20% at 16 years of follow-up. The US PLCO trial showed a smaller effect, partly because the 'control' arm had high contamination with off-protocol PSA testing. Major evidence reviews acknowledge that PSA screening reduces prostate-cancer mortality modestly but also causes harms from overdiagnosis and overtreatment. Current US and European guidance broadly converges on shared decision-making starting at age 45–50 (earlier if Black men, BRCA carriers, or strong family history), with baseline PSA used to stratify follow-up frequency. The right answer is a conversation, not a reflex.

Most men in DACH and the US under-use the check-ups available to them. A realistic structure for your 40s:

Germany. Statutory insurance covers the Gesundheits-Untersuchung (formerly Check-up 35), generally every three years from age 35. It includes blood pressure, basic blood glucose and cholesterol panel, urine, and a clinical exam. It does not include ApoB, Lp(a), fasting insulin, hsCRP, or a detailed hormone panel. Most of these are available as IGeL or Selbstzahler add-ons through your Hausarzt or a preventive-medicine practice. Ask explicitly.

Austria. The Vorsorgeuntersuchung is broadly similar and free for insured residents from age 18. Many men also see a Wahlarzt for fast access to a urologist or andrologist, with partial Krankenkasse reimbursement. For testosterone or PSA-based decisions, a Wahlarzt urologist is often the most practical route.

Switzerland & United States. In Switzerland, basic insurance covers physician visits after the deductible; preventive blood panels beyond the basics are usually patient-pay. In the US, the standard annual physical is similar to DACH — ask explicitly for ApoB, Lp(a), HbA1c, fasting insulin, hsCRP. Direct-to-consumer labs are widely available; bring results to your physician.

A practical menu in your 40s. Once: Lp(a), full lipid panel including ApoB, HbA1c, fasting insulin, hsCRP, TSH, ferritin, vitamin D, total testosterone (morning), SHBG, baseline PSA. Discuss a baseline ECG. Annually or biannually: home blood pressure, lipid panel, HbA1c, basic metabolic panel, weight and waist, plus a sleep and alcohol review. From the late 40s: coronary artery calcium (CAC) score if cardiovascular risk is intermediate or family history strong; colonoscopy from 45 in the US, 50 in DACH (earlier with family history); ongoing PSA discussion.

The point of a check-up is not to chase numbers but to build a relationship with one trusted physician who knows your trajectory. The men who do well in their 70s mostly started this in their 40s.